Bhatt Darshak K, Boerma Annemarie, Bustos Silvina Odete, Otake Andréia Hanada, Murillo Carrasco Alexis Germán, Reis Patrícia Pintor, Chammas Roger, Daemen Toos, Andrade Luciana Nogueira de Sousa
Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, 9713 AV, The Netherlands.
Center for Translational Research in Oncology (LIM/24), Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, CEP 01246-000, Brazil.
Sci Rep. 2025 Jan 4;15(1):803. doi: 10.1038/s41598-024-82331-9.
Extracellular vesicles (EVs)-mediated communication by cancer cells contributes towards the pro-tumoral reprogramming of the tumor microenvironment. Viral infection has been observed to alter the biogenesis and cargo of EVs secreted from host cells in the context of infectious biology. However, the impact of oncolytic viruses on the cargo and function of EVs released by cancer cells remains unknown. Here we show that upon oncolytic virotherapy with Semliki Forest virus-based replicon particles (rSFV), metastatic melanoma cells release EVs with a distinct biochemical profile and do not lead to suppression of immune cells. Specifically, we demonstrate that viral infection causes a differential loading of regulatory microRNAs (miRNAs) in EVs in addition to changes in their physical features. EVs derived from cancer cells potentially suppress splenocyte proliferation and induce regulatory macrophages. In contrast, EVs obtained from rSFV-infected cells did not exhibit such effects. Our results thus show that rSFV infection induces changes in the immunomodulatory properties of melanoma EVs, which may contribute to enhancing the therapeutic efficacy of virotherapy. Finally, our results show that the use of an oncolytic virus capable of a single-round of infection allows the analysis of EVs secreted from infected cells while preventing interference from extracellular virus particles.
癌细胞通过细胞外囊泡(EVs)介导的通讯有助于肿瘤微环境的促肿瘤重编程。在感染生物学背景下,已观察到病毒感染会改变宿主细胞分泌的EVs的生物发生和货物。然而,溶瘤病毒对癌细胞释放的EVs的货物和功能的影响仍然未知。在这里,我们表明,在用基于Semliki森林病毒的复制子颗粒(rSFV)进行溶瘤病毒治疗后,转移性黑色素瘤细胞释放出具有独特生化特征的EVs,并且不会导致免疫细胞受到抑制。具体而言,我们证明病毒感染除了会改变EVs的物理特征外,还会导致其调节性微小RNA(miRNAs)的差异装载。源自癌细胞的EVs可能会抑制脾细胞增殖并诱导调节性巨噬细胞。相比之下,从rSFV感染的细胞中获得的EVs没有表现出这种效果。因此,我们的结果表明,rSFV感染会诱导黑色素瘤EVs免疫调节特性的变化,这可能有助于提高病毒治疗的疗效。最后,我们的结果表明,使用能够进行单轮感染的溶瘤病毒可以分析感染细胞分泌的EVs,同时防止细胞外病毒颗粒的干扰。